BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1702877)

  • 1. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 19. The classification of carcinogens identified in the rodent bioassay as potential risks to humans: what type of substance should be tested next?
    Clayson DB; Arnold DL
    Mutat Res; 1991 Jan; 257(1):91-106. PubMed ID: 1702877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 17. Can a mechanistic rationale be provided for non-genotoxic carcinogens identified in rodent bioassays?
    Clayson DB
    Mutat Res; 1989 Jul; 221(1):53-67. PubMed ID: 2664495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper No. 5. Genotoxicity tests as predictors of carcinogens: an analysis.
    Douglas GR; Blakey DH; Clayson DB
    Mutat Res; 1988 Jul; 196(1):83-93. PubMed ID: 3292901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How many high production chemicals are rodent carcinogens? Why should we care? What do we need to do about it?
    Johnson FM
    Mutat Res; 2003 Jun; 543(3):201-15. PubMed ID: 12787813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hazard identification: efficiency of short-term tests in identifying germ cell mutagens and putative nongenotoxic carcinogens.
    Waters MD; Stack HF; Jackson MA; Bridges BA
    Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):61-72. PubMed ID: 8143649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural implications of the ICPEMC method for quantifying genotoxicity data.
    Rosenkranz HS; Klopman G
    Mutat Res; 1994 Feb; 305(1):99-116. PubMed ID: 7508550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard.
    Tennant RW
    Mutat Res; 1993 Mar; 286(1):111-8. PubMed ID: 7678907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
    Nesnow S
    Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
    Battershill JM; Fielder RJ
    Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
    Klopman G; Rosenkranz HS
    Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.
    Jansen JD
    Regul Toxicol Pharmacol; 1984 Jun; 4(2):138-44. PubMed ID: 6739865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rodent carcinogens: setting priorities.
    Gold LS; Slone TH; Stern BR; Manley NB; Ames BN
    Science; 1992 Oct; 258(5080):261-5. PubMed ID: 1411524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.